Department of Medical Education, Centre of Innovative Medical Education, Jagiellonian University Medical College, Krakow, Poland.
St Lazarus Hospice, Krakow, Poland.
Palliat Support Care. 2022 Oct;20(5):687-693. doi: 10.1017/S1478951521001176.
The study aimed to assess the reliability and validity of the IPOS-Pol for patient self-reporting.
Patients (>18 years of age) with advanced cancer admitted to three palliative care centers (inpatient units and home-based) were recruited to a multicenter, cross-sectional, observational, prospective study. Participants provided responses to the IPOS-Pol Patient version and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Core 15 - Palliative Care (EORTC QLQ-C15-PAL) Polish version at baseline (T1) and four to seven days later (T2). We assessed test-retest reliability, internal consistency, and construct validity of the tool.
One hundred and eighty patients were included. Test-retest reliability demonstrated no statistically significant differences in the average outcomes of the IPOS-Pol between T1 and T2 (27.2 ± 9.2 vs. 26.5 ± 8.7; > 0.05). The intra-class correlation coefficient between T1 and T2 was = 0.83 ( < 0.0001), the intra-class correlation coefficient for test-retest reliability of the IPOS-Pol items ranged from 0.63 to 0.84 ( < 0.0001), and the Cronbach's coefficient for internal consistency was 0.773. The correlation coefficient between the IPOS-Pol and EORTC QLQ-C15-PAL total score was 0.79 ( < 0.001).
The patient version of the Polish adaptation of IPOS is a valid and reliable outcome measure for assessing symptoms and concerns of individuals receiving palliative care, as well as the quality of care provided.
本研究旨在评估 IPOS-Pol 用于患者自评的可靠性和有效性。
我们招募了年龄大于 18 岁的患有晚期癌症的患者(住院患者和居家患者),在三个姑息治疗中心进行了一项多中心、横断面、观察性、前瞻性研究。参与者在基线(T1)和 4 至 7 天后(T2)时分别填写了 IPOS-Pol 患者版和欧洲癌症研究与治疗组织生活质量问卷核心 15 项-姑息治疗版(EORTC QLQ-C15-PAL)波兰语版。我们评估了该工具的重测信度、内部一致性和结构效度。
共纳入了 180 名患者。IPOS-Pol 在 T1 和 T2 之间的平均结果没有统计学上的显著差异(27.2 ± 9.2 与 26.5 ± 8.7;>0.05)。T1 和 T2 之间的组内相关系数为 = 0.83(<0.0001),IPOS-Pol 项目的重测信度组内相关系数范围为 0.63 至 0.84(<0.0001),内部一致性的 Cronbach's 系数为 0.773。IPOS-Pol 与 EORTC QLQ-C15-PAL 总分的相关系数为 0.79(<0.001)。
波兰语版 IPOS 的患者版是一种有效的、可靠的评估接受姑息治疗的个体的症状和关注点以及提供的护理质量的结果测量工具。